Selective in vitro expansion and efficient retroviral transduction of human CD34+ CD38- haematopoietic stem cells.
Ex vivo expansion of primitive human haematopoietic stem cells (HSC) is clinically relevant for stem cell transplantation and gene therapy. Here, we demonstrate the selective expansion of CD34+CD38- cells from purified CD34+ cells upon stimulation with Flt3-ligand, stem cell factor and thrombopoietin. Over a 100-fold (range 80 to 128-fold) expansion of CD34+CD38- cells was observed with bone marrow and cord blood (CB). The expanded CD34+CD38- cells remained negative for lineage-specific markers and could be induced to differentiate into granulocytes, monocytes, megakaryocytes, erythrocytes, and T and B-lymphocytes in vitro. Lineage differentiation assays with single CD34+CD38- cells showed no loss of multilineage potential of expanded cells after ex vivo culture. We also demonstrated that the increase in frequency of CD34+CD38- cells was not as a result of the downregulation of CD38 expression during the culture. Quantitative analysis showed that the number of 6 week cobblestone area forming cells (CAFCwk6), a measure of proliferating HSC, in cytokine-stimulated CD34+ cells were increased by 20-fold. Expanded CD34+CD38- cells could be transduced efficiently with retroviruses encoding the low affinity nerve growth factor receptor (LNGFR) marker gene (17% to 44%, mean 27%), resulting in long-lasting expression of retroviral-encoded genes in progeny HSC and differentiated progenitors. We conclude that the combination Flt3-ligand (FL), stem cell factor and thrombopoietin (TPO) induced strong ex vivo proliferation of CD34+CD38- cells and that the absolute number of expanded cells with stem cell activity increased substantially in this population.
Ng
Yuk Yin
YY
Departments of Hematology and Immunology, University Medical Center, Utrecht, The Netherlands.
Bloem
Andries C
AC
van Kessel
Berris
B
Lokhorst
Henk
H
Logtenberg
Ton
T
Staal
Frank J T
FJ
D000256:Adenoviridae / Q000235:genetics; D018952:Antigens, CD34; D001854:Bone Marrow Cells / Q000276:immunology; D002452:Cell Count; D002454:Cell Differentiation; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D005312:Fetal Blood; D005822:Genetic Vectors / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D008565:Membrane Proteins / Q000494:pharmacology; D020800:Receptor, Nerve Growth Factor / Q000235:genetics; D019089:Stem Cell Factor / Q000494:pharmacology; D013268:Stimulation, Chemical; D013926:Thrombopoietin / Q000494:pharmacology; D014161:Transduction, Genetic
D018952:Antigens, CD34; D008565:Membrane Proteins; D020800:Receptor, Nerve Growth Factor; D019089:Stem Cell Factor; C084881:flt3 ligand protein; D013926:Thrombopoietin